-
Recoding the gift relationship: views on introducing genomic testing to blood donation New Genet. Soc. (IF 1.8) Pub Date : 2024-02-16 Rachel Thorpe, Vera Raivola, Barbara Masser
This study examines how the institutional context informs the ways in which healthy recipients relate to genomic information. Through focus group data, it considers the trend of blood collection ag...
-
Toxic disruptions: polycystic ovary syndrome in urban India New Genet. Soc. (IF 1.8) Pub Date : 2024-02-13 Anindita Majumdar
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 43, No. 1, 2024)
-
Strategies on personalized medicine and the power of the imagined public New Genet. Soc. (IF 1.8) Pub Date : 2023-09-25 Lotte Groth Jensen, Mette N. Svendsen, Karoliina Snell
Personalized medicine has become a central focus of health and innovation policies in many countries. It is a complex policy field which, in the pursuit of both health and wealth, brings together t...
-
Donors: curious connections in donor conception New Genet. Soc. (IF 1.8) Pub Date : 2023-09-19 Kriss Fearon
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 42, No. 1, 2023)
-
The Muslim genome: postcolonial nation-building through genomics in Pakistan New Genet. Soc. (IF 1.8) Pub Date : 2023-09-12 Tayyaba Jiwani
National genome projects are often celebrated as assertions of genomic sovereignty, with limited critique of their potential as instruments of biopolitical control and extraction by the state. This paper extends analyses of genomics and nationalism by examining how genomics is mobilized in service of an authoritarian nation-state and ideology in Pakistan. Since independence, Pakistan has sought to
-
Siloed discourses: a year-long study of twitter engagement on the use of CRISPR in food and agriculture New Genet. Soc. (IF 1.8) Pub Date : 2023-08-22 Lauren Crossland-Marr, Alexandru Giurca, Maya Tsingos, Matthew A. Schnurr, Adrian Ely, Dominic Glover, Glenn Davis Stone, Klara Fischer
Gene editing technologies are emerging as powerful tools for agricultural development, spurring both hopes and concerns in society. To understand emerging discourses and coalitions around the role of CRISPR gene editing in food and agriculture we map the main actors and themes emerging from English-speaking Twitter networks over the course of one year (2021). Scientific actors are the most active and
-
Being Human during COVID-19 New Genet. Soc. (IF 1.8) Pub Date : 2023-08-18 Robyn Rowe
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 42, No. 1, 2023)
-
Intrinsic responsible innovation in a synthetic biology research project New Genet. Soc. (IF 1.8) Pub Date : 2023-08-17 Ken Taylor, Simon Woods, Alex Johns, Heath Murray
This paper presents, from the perspectives of both social scientists and microbiologists, a case study of the implementation and practice of Responsible Innovation (RI) in a UK-based synthetic biology project. We highlight the impact of interdisciplinary working and examine the benefits that arise from creating the time and space for shared reflection on research. Our discussions over the course of
-
Safe and purposeful genome editing under harmonized regulation for responsible use: views of research experts New Genet. Soc. (IF 1.8) Pub Date : 2023-07-21 Pedro Dias Ramos, Maria Strecht Almeida, I. Anna S. Olsson
CRISPR-Cas9 revolutionized the precise editing of mammalian cells genome. The present study explores genome editing (GE) in the context of the Responsible Research and Innovation framework for emerging technologies, through semi-structured interviews with life sciences researchers worldwide. Our study demonstrates that for researchers in the field, GE technology is viewed as promising but also harboring
-
Use of tissue and health data: attachments and detachments among an enabling public New Genet. Soc. (IF 1.8) Pub Date : 2023-05-25 Lea Skovgaard, Mette N. Svendsen
Personalized medicine aims at tailoring treatment to the individual person through the sourcing of multiple health data from the population. The realization of these ambitions rest on the ability to reuse health data. But what does it take to reuse tissue and data collected from individuals in connection with treatment, for future purposes? It takes an “enabling public” consisting of not only people
-
Consensus too soon: judges’ and lawyers’ views on genetic information use New Genet. Soc. (IF 1.8) Pub Date : 2023-04-13 Fatos Selita, Robert Chapman, Yulia Kovas, Vanessa Smereczynska, Maxim Likhanov, Teemu Toivainen
Timely effective regulation of genetic advances presents a challenge for justice systems. We used a 51-item battery to examine views on major genetics-related issues of those at the forefront of regulating this area – Supreme Court judges (N = 73). We also compared their views with those of other justice stakeholders (N = 210) from the same country (Romania). Judges showed greater endorsement and less
-
Embodiment and everyday cyborgs New Genet. Soc. (IF 1.8) Pub Date : 2023-04-13 Rose Porter
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 42, No. 1, 2023)
-
Healthcare activism: markets, morals, and the collective good New Genet. Soc. (IF 1.8) Pub Date : 2023-04-03 Siobhan Pokorney
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 42, No. 1, 2023)
-
Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare New Genet. Soc. (IF 1.8) Pub Date : 2023-03-28 Yuwan Malakar, Justine Lacey, Natalie A. Twine, Denis C. Bauer
Clinical genomics is a system of multiple stakeholders and institutions. Yet, studies focusing on the comparative perspectives of these stakeholders are limited. This study engages four groups of professionals (clinical geneticists, genetic counselors, laboratory professionals, and researchers) working in clinical genomics to investigate their perceptions of the benefits and risks of using genomics
-
The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries New Genet. Soc. (IF 1.8) Pub Date : 2022-12-20 Rebecca Dimond, Jamie Lewis, Alice Sumner
The 2018 announcement that the world’s first babies had been born following gene editing was unexpected and unanticipated. In this article, we focus on the reaction to the announcement and explore how this revealed implicit and explicit assumptions about the role and responsibilities of scientists and scientific standards. Through analysis of media coverage and public commentary about the birth of
-
The matrix of stem cell research: an approach to rethinking science in society New Genet. Soc. (IF 1.8) Pub Date : 2022-11-11 Michael Morrison
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 4, 2022)
-
Navigating narratives of genetic categorization at the frayed edges of identity New Genet. Soc. (IF 1.8) Pub Date : 2022-10-20 Karen Ann Blom
History can be described as a story, or narrative reporting on past events to create meaning and explanation for the present/future. Narratives of genetic history are presented in the genetic ancestry testing (GAT) results specifically maps, percentages, and related information to consumers expecting “answers” related to identity and belonging. Engaging in thematic narrative analysis I ask how GAT
-
“We are all cousins.” Belgian ancestry and genomic testing in a close-knit community in Northeastern Wisconsin New Genet. Soc. (IF 1.8) Pub Date : 2022-10-20 François Romijn
Drawing on an ethnography of Wisconsin-based descendants of Belgian immigrants, this article explores social dynamics relating to ways lay users of genomic ancestry testing (GAT) understand genomic ancestry and how their understanding raises questions concerning the construction of their identities. The study focuses on a group that presents interesting features for which the existing literature is
-
Correction New Genet. Soc. (IF 1.8) Pub Date : 2022-10-13
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 3, 2022)
-
Governance through scientism: Taiwan Biobank and public controversy New Genet. Soc. (IF 1.8) Pub Date : 2022-09-15 Wan-Ju Lee, Yu-Yueh Tsai
Based on the concept of “governance through scientism”, this article aims to reveal the tacit practices of the institutional culture of scientism among Taiwan Biobank’s elite scientists, whose imaginaries have shaped the dominance of a deficit model of the public in dealing with public controversy and establishing regulatory mechanisms. Examining three periods of ELSI controversies from 2000 to 2021
-
The challenge of recruiting diverse populations into health research: an embedded social science perspective New Genet. Soc. (IF 1.8) Pub Date : 2022-09-06 Simon M. Outram, Sara L. Ackerman, Matthew Norstad, Barbara Koenig
Addressing health disparities has become a central remit for conducting health research. In the following paper, we explore the conceptual and methodological challenges posed by the call to recruit medically underserved populations. This exploration of challenges is undertaken from the perspective of social science researchers embedded in a large clinical genomics research study. We suggest that these
-
“It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial New Genet. Soc. (IF 1.8) Pub Date : 2022-09-02 Jennifer Elyse James, Galen Joseph
Adaptive pragmatic clinical trials offer an innovative approach that integrates clinical care and research. Yet, blurring the boundaries between research and clinical care raises questions about how clinicians and investigators balance their patient care and research roles and what types of knowledge and risk assessment are most valued. This paper presents findings from an ethnographic ELSI (Ethical
-
Building the airplane while flying it: tracking the transformation of novel sequencing practices into clinical services New Genet. Soc. (IF 1.8) Pub Date : 2022-09-01 Rayna Rapp, Simon Outram
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 3, 2022)
-
The pathos of precision New Genet. Soc. (IF 1.8) Pub Date : 2022-08-29 Jenny Reardon
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 3, 2022)
-
Environmental sustainability and biobanking: a pilot study of the field New Genet. Soc. (IF 1.8) Pub Date : 2022-08-29 G. Samuel, F. Hardcastle, A.M. Lucassen
Biobanks have expanded dramatically over the past few decades, as have their storage and computational requirements. These requirements have environmental impacts, including mineral extraction and manufacturing processes associated with digital infrastructures, carbon emissions related to sample storage and data storage and analysis, and associated waste. Here we analyse whether biobanks have any specific
-
“Doing Good” in U.S. Cancer Genomics? Valuation practices across the boundaries of research and care in rural community oncology New Genet. Soc. (IF 1.8) Pub Date : 2022-07-12 Katherine Weatherford Darling, Michael Kohut, Susan Leeds, Eric C. Anderson, Paul K.J. Han
Genomic Tumour Testing (GTT) is an emerging site of “experimental care” in oncology [Cambrosio, Alberto, Peter Keating, Etienne Vignola-Gagné, Sylvain Besle, and Pascale Bourret. 2018a. “Extending Experimentation: Oncology’s Fading Boundary Bbetween Research and Care.” New Genetics and Society 37 (3): 207–226. doi: 10.1080/14636778.2018.1487281]. Few efforts to implement GTT have reached community
-
Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns New Genet. Soc. (IF 1.8) Pub Date : 2022-06-26 Corinna C.A. Clark, Felicity K. Boardman
Whole genome sequencing (WGS) is being considered as a tool to deliver newborn screening (NBS) internationally. Its use would dramatically increase the number of genetic variants identified, presenting a host of ethical, social, and practical considerations. A scoping review was conducted to examine the acceptability of WGS-NBS among parents, the public, and health professionals. Parent/public groups
-
In Memoriam of Andrew Webster New Genet. Soc. (IF 1.8) Pub Date : 2022-06-10 Richard Tutton, Adam Hedgecoe, Gareth Thomas, Ros Williams, Clancy Pegg
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 1, 2022)
-
Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations New Genet. Soc. (IF 1.8) Pub Date : 2022-05-26 Bradley Lonergan, Richard A. Williams, Takuya Matsushige, Laura L. Machin
Umbilical cord blood unit (CBU) “quantity” continues to grow internationally, while cord blood transplantation (CBT) “quality” remains poorly defined and subject to uncertainty. CBT “quality” is affected by both the product (i.e. CBUs) and CBT processes, with “best practice” varying across countries. To improve overall CBT “quality”, we need to better understand the uncertainty associated with CBUs
-
“Idealists and capitalists”: ownership attitudes and preferences in genomic citizen science New Genet. Soc. (IF 1.8) Pub Date : 2022-05-13 Christi J. Guerrini, Jorge L. Contreras, Whitney Bash Brooks, Isabel Canfield, Meredith Trejo, Amy L. McGuire
The perspectives of genomic citizen scientists on ownership of research outputs are not well understood, yet they are useful for identifying alignment of participant expectations and project practices and can help guide efforts to develop innovative tools and strategies for managing ownership claims. Here, we report findings from 52 interviews conducted in 2018 and 2019 to understand genomic citizen
-
The new stage of public engagement with science in the digital media environment: citizen science communicators in the discussion of GMOs on Zhihu New Genet. Soc. (IF 1.8) Pub Date : 2022-04-26 Zheng Yang
In the digital media environment, public engagement with science around controversial scientific topics such as genetically modified organisms (GMOs) has greatly expanded. But the public's role as science communicators in such engagement has been virtually ignored. Through an online ethnography of the discussion of GMOs on Zhihu, the biggest Chinese knowledge-sharing network, this study identifies
-
Freezing fertility: oocyte cryopreservation and the gender politics of aging New Genet. Soc. (IF 1.8) Pub Date : 2022-04-24 Anindita Majumdar
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 2, 2022)
-
Conviction: the making and unmaking of the violent brain New Genet. Soc. (IF 1.8) Pub Date : 2022-03-08 Owen Whooley
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 2, 2022)
-
Laboring bodies and the quantified self New Genet. Soc. (IF 1.8) Pub Date : 2022-01-31 Michael Crawley
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 1, 2022)
-
Gene drive communication: exploring experts’ lived experience of metaphor use New Genet. Soc. (IF 1.8) Pub Date : 2022-01-12 Brigitte Nerlich, Aleksandra Stelmach
Metaphors have been crucial in making genetics and genomics public, from the code and the book of life to genetic scissors and gene surgery. A new field is emerging called “gene drive” – a range of controversial technologies that can potentially be used for the eradication or conservation of animal species. At the same time, metaphors are emerging to talk about the promises and dangers of “gene drive”
-
Editorial: themed issue: understanding the technical and social landscape of gene editing New Genet. Soc. (IF 1.8) Pub Date : 2021-12-14 Rebecca Dimond, Jamie Lewis, Gareth Thomas
(2021). Editorial: themed issue: understanding the technical and social landscape of gene editing. New Genetics and Society: Vol. 40, Understanding the technical and social landscape of gene editing, pp. 361-366.
-
The platforming of human embryo editing: prospecting “disease free” futures New Genet. Soc. (IF 1.8) Pub Date : 2021-11-28 Ayo Wahlberg, Dong Dong, Priscilla Song, Zhu Jianfeng
In November 2018, a scientific scandal broke when news emerged that the world’s first gene edited babies had been born in China on the eve of the 2nd International Summit on Human Genome Editing in Hong Kong. He Jiankui had recruited a total of seven couples who were in need of fertility treatment to participate in an effort to clinically apply human embryo editing with the promise that, if successful
-
The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies New Genet. Soc. (IF 1.8) Pub Date : 2021-11-29 Terese Knoppers, Elisabeth Beauchamp, Ken Dewar, Sarah Kimmins, Guillaume Bourque, Yann Joly, Charles Dupras
While much attention has gone towards ethical, legal, and social implications of direct-to-consumer genetic testing over the past decades, the rise of new forms of consumer omics has largely escaped scrutiny. In this paper, we analyze the product descriptions, promotional messages, terms of service, and privacy policies of five epigenetic and seven microbiomic testing companies. The advent of such
-
“It didn’t mean anything” – moving within a landscape of knowledge to interpret genetics and genetic test results within familial cancer concerns New Genet. Soc. (IF 1.8) Pub Date : 2021-12-01 Mavis Machirori, Christine Patch, Alison Metcalfe
Genetics is increasingly defining how we understand health and disease, affecting for some, their understanding of inherited disease, and the meaning of medical genetic information. When interpretations of hereditary conditions are determined, partly, by one’s familial experience of heritable characteristics and partly by various other lived experiences, the meaning of genetics becomes highly personal
-
The rise of the biocyborg: synthetic biology, artificial chimerism and human enhancement New Genet. Soc. (IF 1.8) Pub Date : 2021-12-03 Léo Pio-Lopez
Applying technologies into the human body makes a hybrid human/machine: a cyborg. We identified four types of cyborgs in the literature: the original cyborg, enhanced temporarily for space exploration, the science-fiction cyborg, the “Haraway cyborg” used to critic the dualisms and the “everyday cyborg” who became one by necessity, and learns to live with the implanted technologies. We propose in this
-
Many thanks for New Genetics and Society reviewers New Genet. Soc. (IF 1.8) Pub Date : 2021-12-14
(2021). Many thanks for New Genetics and Society reviewers. New Genetics and Society: Vol. 40, Understanding the technical and social landscape of gene editing, pp. i-i.
-
“If relatives inherited the gene, they should inherit the data.” Bringing the family into the room where bioethics happens New Genet. Soc. (IF 1.8) Pub Date : 2021-12-13 Deborah R. Gordon, Barbara A. Koenig
Biological kin share up to half of their genetic material, including predisposition to disease. Thus, variants of clinical significance identified in each individual’s genome can implicate an exponential number of relatives at potential risk. This has renewed the dilemma over family access to research participant’s genetic results, since prevailing US practices treat these as private, controlled by
-
Bio-imperialism. Disease, terror and the construction of national fragility New Genet. Soc. (IF 1.8) Pub Date : 2021-12-11 John Harrington
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 2, 2022)
-
Promising precision medicine: how patients, clinicians and caregivers work to realize the potential of genomics-informed cancer care New Genet. Soc. (IF 1.8) Pub Date : 2021-12-11 Sara L. Ackerman
This paper examines the emerging field of molecular oncology, in which targeted treatments are sought for patients who have exhausted standard cancer therapies. Drawing on an ethnographic study at a U.S. academic medical center, and building on recent theoretical work examining potentiality as a site where expectations, meaning and value are produced, I describe efforts to translate genetic information
-
“Donating with eyes shut”: attitudes regarding DNA donation to a large-scale biobank in Israel New Genet. Soc. (IF 1.8) Pub Date : 2021-12-03 Aviad Raz, Yael Hashiloni-Dolev
DNA collection raises ethical, legal, and social issues around privacy, consent, participatory science, benefits and risks, biodata governance, and, ultimately, trust. While there is a consensus that DNA biobanks’ success depends on public trust, more evidence is needed regarding the determinants, production, and preservation of such trust. We draw on 14 semi-structured interviews with participants
-
The color of creatorship: intellectual property, race, and the making of Americans New Genet. Soc. (IF 1.8) Pub Date : 2021-07-15 Jin R. Choi
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 1, 2022)
-
Thinking the unthinkable: how did human germline genome editing become ethically acceptable? New Genet. Soc. (IF 1.8) Pub Date : 2021-07-02 Paul A. Martin, Ilke Turkmendag
Two major reports in the UK and USA have recently sanctioned as ethically acceptable genome editing of future generations for the treatment of serious rare inherited conditions. This marks an important turning point in the application of recombinant DNA techniques to humans. The central question this paper addresses is how did it became possible for human genetic engineering (HGE) of future generations
-
Reinterpreting “genetic identity” in the regulatory and ethical context of heritable genome editing New Genet. Soc. (IF 1.8) Pub Date : 2021-06-15 Ying-Qi Liaw, Ilke Turkmendag, Kathryn Hollingsworth
Heritable genome editing (HGE) is prohibited by several international conventions for a number of reasons, including the protection of “genetic identity.” This article provides a conceptual analysis of the concept of “genetic identity” and offers normative reflections as to how it should be interpreted in the context of HGE. In particular, this article examines the purported right to retain “genetic
-
Vaccine court – the law and politics of injury New Genet. Soc. (IF 1.8) Pub Date : 2021-05-29 Tom Douglass
Published in New Genetics and Society: Critical Studies of Contemporary Biosciences (Vol. 41, No. 1, 2022)
-
GUYnecology: the missing science of men’s reproductive health New Genet. Soc. (IF 1.8) Pub Date : 2021-02-28 Joe Strong
(2021). GUYnecology: the missing science of men’s reproductive health. New Genetics and Society: Vol. 40, Understanding the technical and social landscape of gene editing, pp. 622-624.
-
Mapping humanity: how modern genetics is changing criminal justice, personalized medicine, and our identities New Genet. Soc. (IF 1.8) Pub Date : 2021-02-28 Daniel Chavez-Yenter
(2021). Mapping humanity: how modern genetics is changing criminal justice, personalized medicine, and our identities. New Genetics and Society: Vol. 40, Understanding the technical and social landscape of gene editing, pp. 624-628.
-
Avian reservoirs: virus hunters and birdwatchers in Chinese sentinel posts New Genet. Soc. (IF 1.8) Pub Date : 2021-02-24 Stephen Molldrem
(2021). Avian reservoirs: virus hunters and birdwatchers in Chinese sentinel posts. New Genetics and Society: Vol. 40, Understanding the technical and social landscape of gene editing, pp. 620-621.
-
Organizing precision oncology: introduction to the special issue New Genet. Soc. (IF 1.8) Pub Date : 2021-02-16 Pascale Bourret, Patrick Castel, Henri Bergeron, Alberto Cambrosio
(2021). Organizing precision oncology: introduction to the special issue. New Genetics and Society: Vol. 40, Organizing precision oncology, pp. 1-6.
-
Local mutations: on the tentative beginnings of molecular oncology in Britain 1980–2000 New Genet. Soc. (IF 1.8) Pub Date : 2021-02-07 Steve Sturdy
Popular and scientific accounts of the molecularisation of cancer typically attribute it to advances in laboratory science, particularly molecular geneticists. However, historical research has indicated that clinical expertise input was often vital for advancing such work. The present paper reinforces that view. Looking in detail at British research into the molecular genetics of familial cancers during
-
Beyond full jurisdiction: pathology and inter-professional relations in precision medicine New Genet. Soc. (IF 1.8) Pub Date : 2020-12-23 Henri Bergeron, Patrick Castel, Audrey Vézian
The rise of precision medicine represents a challenge for pathology, which must now more closely link research and diagnostic and collaborate on new bases with other specialties. Our paper is based on the study of four French cancer centers invested in developing precision medicine. Molecular biology is particularly threatening for pathologists in settings where medical oncologists and biologists believe
-
Organizing the precision clinic: arranging expertise, knowledge and technologies in cancer precision medicine clinical trials New Genet. Soc. (IF 1.8) Pub Date : 2021-02-07 Stefano Crabu
The aim of this article, which draws on qualitative research focussed on working practices around a genomic-informed clinical trial, is to contribute to the ongoing debate on how care professionals and biomedical investigators mobilize collective expertise in and across organizational settings to shape so-called precise knowledge in cancer medicine. In so doing, the paper discusses three interrelated
-
Data curation-research: practices of data standardization and exploration in a precision medicine database New Genet. Soc. (IF 1.8) Pub Date : 2020-12-20 Niccolò Tempini
Key to precision medicine is the development of expert database projects that gather data, integrate them in the pre-existing database, and publish the product of their processing for others to make use of. Increasingly, it is required that data infrastructure managers and curators pursue and lead research projects on the data so as to learn about new ways data could be used or information that could
-
Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities New Genet. Soc. (IF 1.8) Pub Date : 2021-01-17 Anne Kerr, Choon Key Chekar, Julia Swallow, Emily Ross, Sarah Cunningham-Burley
As precision oncology has evolved, patients and their families have become more involved in efforts to access these treatments via fundraising and campaigning that take place outside of the larger cancer charities. In this paper, we explore the solidarities, networks, and emotional work of the UK-based access advocates, drawing on the stories of nine advocates, which included interviews and content
-
Local mutations: on the tentative beginnings of molecular oncology in Britain 1980–2000 New Genet. Soc. (IF 1.8) Pub Date : 2021-02-07 Steve Sturdy
Popular and scientific accounts of the molecularisation of cancer typically attribute it to advances in laboratory science, particularly molecular geneticists. However, historical research has indicated that clinical expertise input was often vital for advancing such work. The present paper reinforces that view. Looking in detail at British research into the molecular genetics of familial cancers during
-
I am a Viking! DNA, popular culture and the construction of geneticized identity New Genet. Soc. (IF 1.8) Pub Date : 2021-01-31 Daniel Strand, Anna Källén
In this article, we analyze how genetic genealogy reshapes popular notions of historical identity, as it facilitates a genetically informed understanding of ethnicity and ancestry. Drawing on interviews with Swedish, British and American individuals who have employed genetic ancestry tests (GATs) to prove ancestral connections to Vikings, we explore how the desire to “be a Viking” is articulated through